MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 143 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,769,899 | +34.1% | 666,187 | +62.4% | 0.00% | +50.0% |
| Q1 2024 | $3,556,407 | +4466.2% | 410,197 | +3349.6% | 0.00% | – |
| Q4 2023 | $77,886 | -34.5% | 11,891 | 0.0% | 0.00% | – |
| Q3 2023 | $118,910 | -13.8% | 11,891 | +7.2% | 0.00% | – |
| Q2 2023 | $137,899 | -16.2% | 11,094 | -5.5% | 0.00% | – |
| Q1 2023 | $164,519 | -17.6% | 11,743 | -15.8% | 0.00% | – |
| Q4 2022 | $199,610 | -85.6% | 13,949 | -74.2% | 0.00% | -100.0% |
| Q3 2022 | $1,382,000 | -92.4% | 54,141 | -91.6% | 0.00% | -92.3% |
| Q2 2022 | $18,220,000 | +3.0% | 641,349 | +27.8% | 0.01% | +18.2% |
| Q1 2022 | $17,695,000 | -26.0% | 501,682 | -12.1% | 0.01% | -21.4% |
| Q4 2021 | $23,913,000 | -20.8% | 570,707 | -7.3% | 0.01% | -30.0% |
| Q3 2021 | $30,201,000 | +46.8% | 615,341 | +24.8% | 0.02% | +53.8% |
| Q2 2021 | $20,571,000 | +8579.7% | 492,932 | +7304.7% | 0.01% | – |
| Q1 2021 | $237,000 | – | 6,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |